Dr Katsiaryna Usachova

Visiting Scientist Molecules from Nature

Microorganisms, in particular actinomycete bacteria, are a very rich source of chemical diversity.

Secondary metabolites they produce often have potent bioactivities, which have been successfully harnessed in commercial production of most known classes of medicines.

It is essential to discover new compounds, to achieve further developments in medicine, and to counter the growing rise of resistance to existing drugs.

Katsiaryna’s work focuses on genetic engineering of biosynthetic pathways for production of novel or biologically inaccessible compounds, discovery and identification of bacterial secondary metabolites, and elucidation of novel enzymology.